Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections

Journal of General Virology

Volumn 95, Issue PART 1, 2014, Pages 1-15

  McLay, Lisa ^a   Liang, Yuying ^a   Ly, Hinh ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FATTY ACID BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA; VACCINIA VACCINE; VIRUS ANTIGEN; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ARENAVIRUS; ARENAVIRUS INFECTION; BACTERIAL INFECTION; CAUSE OF DEATH; COMPARATIVE STUDY; CROSS PROTECTION; CYTOKINE PRODUCTION; CYTOKINE STORM; FATALITY; GEOGRAPHIC DISTRIBUTION; HEMORRHAGIC FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; HYPERTRANSAMINASEMIA; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; JUNIN VIRUS; LASSA FEVER; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MASTOMYS NATALENSIS; MEDICAL DEVICE; MOLECULAR PATHOLOGY; MORBIDITY; MUS MUSCULUS; NATURAL HOST; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SPONTANEOUS ABORTION; VASCULAR ENDOTHELIUM; VESICULAR STOMATITIS VIRUS; VIREMIA; VIRUS ENTRY; VIRUS INFECTION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 84890285794     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.057000-0     Document Type: Review

References (130)

1. Abraham, J., Kwong, J. A., Albariño, C. G., Lu, J. G., Radoshitzky, S. R., Salazar-Bravo, J., Farzan, M., Spiropoulou, C. F. & Choe, H. (2009). Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog 5, e1000358.
2. Aguilar, P. V., Camargo, W., Vargas, J., Guevara, C., Roca, Y., Felices, V., Laguna-Torres, V. A., Tesh, R., Ksiazek, T. G. & Kochel, T. J. (2009). Reemergence of Bolivian hemorrhagic fever, 2007-2008. Emerg Infect Dis 15, 1526-1528.
3. Albariño, C. G., Bird, B. H., Chakrabarti, A. K., Dodd, K. A., Flint, M., Bergeron, É., White, D. M. & Nichol, S. T. (2011). The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain. J Virol 85, 10404-10408.
4. Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L. & Delgado, R. (2002). C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76, 6841-6844.
5. Ambrosio, A., Saavedra, M., Mariani, M., Gamboa, G. & Maiza, A. (2011). Argentine hemorrhagic fever vaccines. Hum Vaccin 7, 694-700.
6. Andersen, K. G., Shylakhter, I., Tabrizi, S., Grossman, S. R., Happi, C. T. & Sabeti, P. C. (2012). Genome-wide scans provide evidence for positive selection of genes implicated in Lassa fever. Philos Trans R Soc Lond B Biol Sci 367, 868-877.
7. Andrews, B. S., Theofilopoulos, A. N., Peters, C. J., Loskutoff, D. J., Brandt, W. E. & Dixon, F. J. (1978). Replication of dengue and Junin viruses in cultured rabbit and human endothelial cells. Infect Immun 20, 776-781.
8. Andrews, N. C., Fleming, M. D. & Levy, J. E. (1999). Molecular insights into mechanisms of iron transport. Curr Opin Hematol 6, 61-64.
9. Baize, S., Kaplon, J., Faure, C., Pannetier, D., Georges-Courbot, M.-C. & Deubel, V. (2004). Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J Immunol 172, 2861-2869.
10. Baize, S., Marianneau, P., Loth, P., Reynard, S., Journeaux, A., Chevallier, M., Tordo, N., Deubel, V. & Contamin, H. (2009). Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys. J Virol 83, 5890-5903.
11. Barrera Oro, J. G. & Eddy, G. A. (1982). Characteristics of candidate live attenuated Junin virus vaccine. In IV International Conference on Comparative Virology, Banff, Alberta, Canada: Abstract S4-10.
12. Barrera Oro, J. G. & Lupton, H. W. (1988). Cross-protection against Machupo virus with Candid #1 live-attenuated Junin virus vaccine. I. The postvaccination prechallenge immune response. In Second International Conference on the Impact of Viral Diseases on the Development of Latin American Countries and the Caribbean Region, Buenos Aires, Argentina.
13. Beyer, W. R., Pöpplau, D., Garten, W., von Laer, D. & Lenz, O. (2003). Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J Virol 77, 2866-2872.
14. Bonthius, D. J. (2012). Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult. Semin Pediatr Neurol 19, 89-95.
15. Borrow, P. & Oldstone, M. B. A. (1994). Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology 198, 1-9.
16. Botten, J., Whitton, J. L., Barrowman, P., Sidney, J., Whitmire, J. K., Alexander, J., Kotturi, M. F., Sette, A. & Buchmeier, M. J. (2010). A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans. J Virol 84, 9947-9956.
17. Bredenbeek, P. J., Molenkamp, R., Spaan, W. J. M., Deubel, V., Marianneau, P., Salvato, M. S., Moshkoff, D., Zapata, J., Tikhonov, I. & other authors (2006). A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology 345, 299-304.
18. Brindley, M. A., Hunt, C. L., Kondratowicz, A. S., Bowman, J., Sinn, P. L., McCray, P. B., Jr, Quinn, K., Weller, M. L., Chiorini, J. A. & Maury, W. (2011). Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology 415, 83-94.
19. Brunotte, L., Lelke, M., Hass, M., Kleinsteuber, K., Becker-Ziaja, B. & Günther, S. (2011). Domain structure of Lassa virus L protein. J Virol 85, 324-333.
20. Buchmeier, M., Bowen, M. & Peters, C. (2001). Arenaviridae: The Viruses and Their Replication. In Fields Virology, 4th edn, pp. 1635-1668. Edited by D. Knipe & P. Howley. Philadelphia, PA: Lippincott-Raven Publisher.
21. CDC (Centers for Disease Control and Prevention) (2008). Brief report: Lymphocytic choriomeningitis virus transmitted through solid organ transplantation-Massachusetts, 2008. MMWR Morb Mortal Wkly Rep 57, 799-801.
22. Charrel, R. N. & de Lamballerie, X. (2003). Arenaviruses other than Lassa virus. Antiviral Res 57, 89-100.
23. Childs, J. & Peters, C. (1993). Ecology and epidemiology of arenaviruses and their hosts. In The Arenaviridae, pp. 331-384. Edited by M. Salvato. New York: Plenum Press.
24. Coimbra, T. L. M., Nassar, E. S., de Souza, L. T. M., Ferreira, I. B., Rocco, I. M., Burattini, M. N., Travassos da Rosa, A. P. A., Vasconcelos, P. F. C. & other authors (1994). New arenavirus isolated in Brazil. Lancet 343, 391-392.
25. Cummins, D., Fisher-Hoch, S. P., Walshe, K. J., Mackie, I. J., McCormick, J. B., Bennett, D., Perez, G., Farrar, B. & Machin, S. J. (1989). A plasma inhibitor of platelet aggregation in patients with Lassa fever. Br J Haematol 72, 543-548.
26. Cummins, D., McCormick, J. B., Bennett, D., Samba, J. A., Farrar, B., Machin, S. J. & Fisher-Hoch, S. P. (1990a). Acute sensorineural deafness in Lassa fever. JAMA 264, 2093-2096.
27. Cummins, D., Molinas, F. C., Lerer, G., Maiztegui, J. I., Faint, R. & Machin, S. J. (1990b). A plasma inhibitor of platelet aggregation in patients with Argentine hemorrhagic fever. Am J Trop Med Hyg 42, 470-475.
28. de Bracco, M. M. E., Rimoldi, M. T., Cossio, P. M., Rabinovich, A., Maiztegui, J. I., Carballal, G. & Arana, R. M. (1978). Argentine hemorrhagic fever. Alterations of the complement system and anti-Junin-virus humoral response. N Engl J Med 299, 216-221.
29. de Manzione, N., Salas, R. A., Paredes, H., Godoy, O., Rojas, L., Araoz, F., Fulhorst, C. F., Ksiazek, T. G., Mills, J. N. & other authors (1998). Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin Infect Dis 26, 308-313.
30. Delgado, S., Erickson, B. R., Agudo, R., Blair, P. J., Vallejo, E., Albariño, C. G., Vargas, J., Comer, J. A., Rollin, P. E. & other authors (2008). Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog 4, e1000047.
31. Demogines, A., Abraham, J., Choe, H., Farzan, M. & Sawyer, S. L. (2013). Dual host-virus arms races shape an essential housekeeping protein. PLoS Biol 11, e1001571.
32. Eichler, R., Lenz, O., Strecker, T., Eickmann, M., Klenk, H.-D. & Garten, W. (2003a). Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor. EMBO Rep 4, 1084-1088.
33. Eichler, R., Lenz, O., Strecker, T. & Garten, W. (2003b). Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett 538, 203-206.
34. Elsner, B., Schwarz, E., Mando, O. G., Maiztegui, J. & Vilches, A. (1973). Pathology of 12 fatal cases of Argentine hemorrhagic fever. Am J Trop Med Hyg 22, 229-236.
35. Emonet, S. F., Seregin, A. V., Yun, N. E., Poussard, A. L., Walker, A. G., de la Torre, J. C. & Paessler, S. (2011). Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and liveattenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. J Virol 85, 1473-1483.
36. Enria, D. A. & Maiztegui, J. I. (1994). Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res 23, 23-31.
37. Enria, D. A., Briggiler, A. M., Levis, S., Vallejos, D., Maiztegui, J. I. & Canonico, P. G. (1987). Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antiviral Res 7, 353-359.
38. Enria, D. A., Briggiler, A. M. & Sánchez, Z. (2008). Treatment of Argentine hemorrhagic fever. Antiviral Res 78, 132-139.
39. Fan, L., Briese, T. & Lipkin, W. I. (2010). Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 84, 1785-1791.
40. Fischer, S. A., Graham, M. B., Kuehnert, M. J., Kotton, C. N., Srinivasan, A., Marty, F. M., Comer, J. A., Guarner, J., Paddock, C. D. & other authors (2006). Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354, 2235-2249.
41. Fisher-Hoch, S., McCormick, J. B., Sasso, D. & Craven, R. B. (1988). Hematologic dysfunction in Lassa fever. J Med Virol 26, 127-135.
42. Fisher-Hoch, S. P., Hutwagner, L., Brown, B. & McCormick, J. B. (2000). Effective vaccine for lassa fever. J Virol 74, 6777-6783.
43. Flatz, L., Rieger, T., Merkler, D., Bergthaler, A., Regen, T., Schedensack, M., Bestmann, L., Verschoor, A., Kreutzfeldt, M. & other authors (2010). T cell-dependence of Lassa fever pathogenesis. PLoS Pathog 6, e1000836.
44. Fulhorst, C. E., Bowen, M. D., Salas, R. A., deManzione, N. M. C., Duno, G., Utrera, A., Ksiazek, T. G., Peters, C. J., Nichol, S. T. & other authors (1997). Isolation and characterization of pirital virus, a newly discovered South American arenavirus. Am J Trop Med Hyg 56, 548-553.
45. Fulhorst, C. F., Cajimat, M. N. B., Milazzo, M. L., Paredes, H., de Manzione, N. M. C., Salas, R. A., Rollin, P. E. & Ksiazek, T. G. (2008). Genetic diversity between and within the arenavirus species indigenous to western Venezuela. Virology 378, 205-213.
46. Geisbert, T. W., Jones, S., Fritz, E. A., Shurtleff, A. C., Geisbert, J. B., Liebscher, R., Grolla, A., Ströher, U., Fernando, L. & other authors (2005). Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2, e183.
47. Gomez, R. M., Pozner, R. G., Lazzari, M. A., D'Atri, L. P., Negrotto, S., Chudzinski-Tavassi, A. M., Berría, M. I. & Schattner, M. (2003). Endothelial cell function alteration after Junin virus infection. Thromb Haemost 90, 326-333.
48. Goñi, S. E., Iserte, J. A., Ambrosio, A. M., Romanowski, V., Ghiringhelli, P. D. & Lozano, M. E. (2006). Genomic features of attenuated Junín virus vaccine strain candidate. Virus Genes 32, 37-41.
49. Gramberg, T., Hofmann, H., Möller, P., Lalor, P. F., Marzi, A., Geier, M., Krumbiegel, M., Winkler, T., Kirchhoff, F. & other authors (2005). LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 340, 224-236.
50. Groseth, A., Hoenen, T., Weber, M., Wolff, S., Herwig, A., Kaufmann, A. & Becker, S. (2011). Tacaribe virus but not Junin virus infection induces cytokine release from primary human monocytes and macrophages. PLoS Negl Trop Dis 5, e1137.
51. Günther, S. & Lenz, O. (2004). Lassa virus. Crit Rev Clin Lab Sci 41, 339-390.
52. Harmon, B., Kozina, C., Maar, D., Carpenter, T. S., Branda, C. S., Negrete, O. A. & Carson, B. D. (2013). Identification of critical amino acids within the nucleoprotein of Tacaribe virus important for antiinterferon activity. J Biol Chem 288, 8702-8711.
53. Harrison, L. H., Halsey, N. A., McKee, K. T., Jr, Peters, C. J., Barrera Oro, J. G., Briggiler, A. M., Feuillade, M. R. & Maiztegui, J. I. (1999). Clinical case definitions for Argentine hemorrhagic fever. Clin Infect Dis 28, 1091-1094.
54. Hastie, K. M., Kimberlin, C. R., Zandonatti, M. A., MacRae, I. J. & Saphire, E. O. (2011). Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 39 to 59 exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A 108, 2396-2401.
55. Heller, M. V., Saavedra, M. C., Falcoff, R., Maiztegui, J. I. & Molinas, F. C. (1992). Increased tumor necrosis factor-α levels in Argentine hemorrhagic fever. J Infect Dis 166, 1203-1204.
56. Heller, M. V., Marta, R. F., Sturk, A., Maiztegui, J. I., Hack, C. E., Cate, J. W. & Molinas, F. C. (1995). Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Thromb Haemost 73, 368-373.
57. Jahrling, P. B., Trotter, R. W., Barrera Oro, J. G., Lupton, H. W., Cosgriff, T. M., Lewis, R. W., Parrish, D. B., Smith, S. B. & Peters, C. J. (1988). Cross-protection against Machupo virus with Candid #1 Junin virus vaccine: III, post-challenge clinical findings. In Second International Conference on the Impact of Viral Diseases on the Development of Latin American Countries and the Caribbean Region, p. E3. Mar del Plata, Argentina.
58. Jiang, X., Dalebout, T. J., Bredenbeek, P. J., Carrion, R., Jr, Brasky, K., Patterson, J., Goicochea, M., Bryant, J., Salvato, M. S. & Lukashevich, I. S. (2011). Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. Vaccine 29, 1248-1257.
59. Jiang, X., Huang, Q., Wang, W., Dong, H., Ly, H., Liang, Y. & Dong, C. (2013). Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression. J Biol Chem 288, 16949-16959.
60. Johnson, K. M., Kuns, M. L., Mackenzie, R. B., Webb, P. A. & Yunker, C. E. (1966). Isolation of Machupo virus from wild rodent Calomys callosus. Am J Trop Med Hyg 15, 103-106.
61. Johnson, K. M., Halstead, S. B. & Cohen, S. N. (1967). Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. Prog Med Virol 9, 105-158.
62. Johnson, K. M., McCormick, J. B., Webb, P. A., Smith, E. S., Elliott, L. H. & King, I. J. (1987). Clinical virology of Lassa fever in hospitalized patients. J Infect Dis 155, 456-464.
63. Kunz, S., Sevilla, N., McGavern, D. B., Campbell, K. P. & Oldstone, M. B. A. (2001). Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan. J Cell Biol 155, 301-310.
64. Kunz, S., Rojek, J. M., Kanagawa, M., Spiropoulou, C. F., Barresi, R., Campbell, K. P. & Oldstone, M. B. A. (2005). Posttranslational modification of α-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J Virol 79, 14282-14296.
65. Levis, S. C., Saavedra, M. C., Ceccoli, C., Feuillade, M. R., Enria, D. A., Maiztegui, J. I. & Falcoff, R. (1985). Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J Interferon Res 5, 383-389.
66. Lukashevich, I. S. (2013). The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines 12, 71-86.
67. Lukashevich, I. S., Clegg, J. C. S. & Sidibe, K. (1993). Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. J Med Virol 40, 210-217.
68. Lukashevich, I. S., Maryankova, R., Vladyko, A. S., Nashkevich, N., Koleda, S., Djavani, M., Horejsh, D., Voitenok, N. N. & Salvato, M. S. (1999). Lassa and Mopeia virus replication in human monocytes/ macrophages and in endothelial cells: different effects on IL-8 and TNF-α gene expression. J Med Virol 59, 552-560.
69. Lukashevich, I. S., Carrion, R., Jr, Salvato, M. S., Mansfield, K., Brasky, K., Zapata, J., Cairo, C., Goicochea, M., Hoosien, G. E. & other authors (2008). Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine 26, 5246-5254.
70. MacNeil, A., Ströher, U., Farnon, E., Campbell, S., Cannon, D., Paddock, C. D., Drew, C. P., Kuehnert, M., Knust, B. & other authors (2012). Solid organ transplant-associated lymphocytic choriomeningitis, United States, 2011. Emerg Infect Dis 18, 1256-1262.
71. Mahanty, S., Bausch, D. G., Thomas, R. L., Goba, A., Bah, A., Peters, C. J. & Rollin, P. E. (2001). Low levels of interleukin-8 and interferoninducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis 183, 1713-1721.
72. Mahanty, S., Hutchinson, K., Agarwal, S., McRae, M., Rollin, P. E. & Pulendran, B. (2003). Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 170, 2797-2801.
73. Maiztegui, J. I., Laguens, R. P., Cossio, P. M., Casanova, M. B., de la Vega, M. T., Ritacco, V., Segal, A., Fernández, N. J. & Arana, R. M. (1975). Ultrastructural and immunohistochemical studies in five cases of Argentine hemorrhagic fever. J Infect Dis 132, 35-43.
74. Maiztegui, J. I., Fernandez, N. J. & de Damilano, A. J. (1979). Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 314, 1216-1217.
75. Marsh, E. W., Leopold, P. L., Jones, N. L. & Maxfield, F. R. (1995). Oligomerized transferrin receptors are selectively retained by a lumenal sorting signal in a long-lived endocytic recycling compartment. J Cell Biol 129, 1509-1522.
76. Marta, R. F., Montero, V. S., Hack, C. E., Sturk, A., Maiztegui, J. I. & Molinas, F. C. (1999). Proinflammatory cytokines and elastase-α-1-antitrypsin in Argentine hemorrhagic fever. Am J Trop Med Hyg 60, 85-89.
77. Martinez, M. G., Cordo, S. M. & Candurra, N. A. (2007). Characterization of Junin arenavirus cell entry. J Gen Virol 88, 1776-1784.
78. Martinez, M. G., Forlenza, M. B. & Candurra, N. A. (2009). Involvement of cellular proteins in Junin arenavirus entry. Biotechnol J 4, 866-870.
79. Martínez-Sobrido, L., Giannakas, P., Cubitt, B., García-Sastre, A. & de la Torre, J. C. (2007). Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 81, 12696-12703.
80. McCormick, J. B. (1999). Lassa fever. In Emergence and Control of Rodent-borne Viral Diseases, pp. 177-195. Edited by J. F. Saluzzo & B. Dodet. Amsterdam: Elsevier.
81. McCormick, J. B. & Fisher-Hoch, S. P. (2002). Lassa fever. Curr Top Microbiol Immunol 262, 75-109.
82. McCormick, J. B., Webb, P. A., Krebs, J. W., Johnson, K. M. & Smith, E. S. (1987a). A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155, 437-444.
83. McCormick, J. B., King, I. J., Webb, P. A., Johnson, K. M., O'Sullivan, R., Smith, E. S., Trippel, S. & Tong, T. C. (1987b). A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155, 445-455.
84. McCormick, J. B., Mitchell, S. W., Kiley, M. P., Ruo, S. & Fisher-Hoch, S. P. (1992). Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys. J Med Virol 37, 1-7.
85. Mills, J. N., Ellis, B. A., McKee, K. T., Jr, Ksiazek, T. G., Oro, J. G., Maiztegui, J. I., Calderon, G. E., Peters, C. J. & Childs, J. E. (1991). Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. Am J Trop Med Hyg 44, 589-597.
86. Molinas, F. C., de Bracco, M. M. E. & Maiztegui, J. I. (1989). Hemostasis and the complement system in Argentine hemorrhagic fever. Rev Infect Dis 11 (Suppl. 4), S762-S770.
87. Monath, T. P. & Casals, J. (1975). Diagnosis of Lassa fever and the isolation and management of patients. Bull World Health Organ 52, 707-715.
88. Montardit, A. I., Fernandez, M. J., DeSensi, M. R. F., Damilano, A. J. & Maiztegui, J. I. (1979). Neutralizacion de la viremia en enfermos de fiebre hemorragica Argentina tratados con plasma inmune. Medicina (B Aires) 39, 799.
89. Moraz, M.-L. & Kunz, S. (2011). Pathogenesis of arenavirus hemorrhagic fevers. Expert Rev Anti Infect Ther 9, 49-59.
90. Moraz, M.-L., Pythoud, C., Turk, R., Rothenberger, S., Pasquato, A., Campbell, K. P. & Kunz, S. (2013). Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan. Cell Microbiol 15, 689-700.
91. Morin, B., Coutard, B., Lelke, M., Ferron, F., Kerber, R., Jamal, S., Frangeul, A., Baronti, C., Charrel, R. & other authors (2010). The Nterminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog 6, e1001038.
92. Oldstone, M. B. A. & Campbell, K. P. (2011). Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response. Virology 411, 170-179.
93. Paessler, S. & Walker, D. H. (2013). Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 8, 411-440.
94. Pannetier, D., Faure, C., Georges-Courbot, M.-C., Deubel, V. & Baize, S. (2004). Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection. J Virol 78, 10516-10524.
95. Pannetier, D., Reynard, S., Russier, M., Journeaux, A., Tordo, N., Deubel, V. & Baize, S. (2011). Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus. J Virol 85, 8293-8306.
96. Pasqual, G., Rojek, J. M., Masin, M., Chatton, J.-Y. & Kunz, S. (2011). Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog 7, e1002232.
97. Paweska, J. T., Sewlall, N. H., Ksiazek, T. G., Blumberg, L. H., Hale, M. J., Lipkin, W. I., Weyer, J., Nichol, S. T., Rollin, P. E. & other authors (2009). Nosocomial outbreak of novel arenavirus infection, southern Africa. Emerg Infect Dis 15, 1598-1602.
98. Perez, M. & de la Torre, J. C. (2003). Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 77, 1184-1194.
99. Peters, C. J. (2006). Lymphocytic choriomeningitis virus-an old enemy up to new tricks. N Engl J Med 354, 2208-2211.
100. Pfau, C. J. (1996). Arenaviruses. In Medical Microbiology, 4th edn. Edited by S. Baron. Galveston, TX: University of Texas Medical Branch at Galveston.
101. Pinschewer, D. D., Perez, M. & de la Torre, J. C. (2005). Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J Virol 79, 4519-4526.
102. Pythoud, C., Rodrigo, W. W. S. I., Pasqual, G., Rothenberger, S., Martínez-Sobrido, L., de la Torre, J. C. & Kunz, S. (2012). Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε. J Virol 86, 7728-7738.
103. Qi, X., Lan, S., Wang, W., Schelde, L. M., Dong, H., Wallat, G. D., Ly, H., Liang, Y. & Dong, C. (2010). Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468, 779-783.
104. Quirin, K., Eschli, B., Scheu, I., Poort, L., Kartenbeck, J. & Helenius, A. (2008). Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology 378, 21-33.
105. Radoshitzky, S. R., Abraham, J., Spiropoulou, C. F., Kuhn, J. H., Nguyen, D., Li, W., Nagel, J., Schmidt, P. J., Nunberg, J. H. & other authors (2007). Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446, 92-96.
106. Raju, R., Raju, L., Hacker, D., Garcin, D., Compans, R. & Kolakofsky, D. (1990). Nontemplated bases at the 59 ends of Tacaribe virus mRNAs. Virology 174, 53-59.
107. Rodrigo, W. W. S. I., Ortiz-Riaño, E., Pythoud, C., Kunz, S., de la Torre, J. C. & Martínez-Sobrido, L. (2012). Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol 86, 8185-8197.
108. Rojek, J. M. & Kunz, S. (2008). Cell entry by human pathogenic arenaviruses. Cell Microbiol 10, 828-835.
109. Rojek, J. M., Campbell, K. P., Oldstone, M. B. A. & Kunz, S. (2007a). Old World arenavirus infection interferes with the expression of functional αdystroglycan in the host cell. Mol Biol Cell 18, 4493-4507.
110. Rojek, J. M., Spiropoulou, C. F., Campbell, K. P. & Kunz, S. (2007b). Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by α-dystroglycan's hostderived ligands. J Virol 81, 5685-5695.
111. Rojek, J. M., Perez, M. & Kunz, S. (2008a). Cellular entry of lymphocytic choriomeningitis virus. J Virol 82, 1505-1517.
112. Rojek, J. M., Sanchez, A. B., Nguyen, N. T., de la Torre, J.-C. & Kunz, S. (2008b). Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82, 7677-7687.
113. Rojek, J. M., Moraz, M.-L., Pythoud, C., Rothenberger, S., Van der Goot, F. G., Campbell, K. P. & Kunz, S. (2012). Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan. Cell Microbiol 14, 1122-1134.
114. Sabeti, P. C., Varilly, P., Fry, B., Lohmueller, J., Hostetter, E., Cotsapas, C., Xie, X., Byrne, E. H., McCarroll, S. A. & other authors (2007). Genome-wide detection and characterization of positive selection in human populations. Nature 449, 913-918.
115. Sevilla, N., Kunz, S., Holz, A., Lewicki, H., Homann, D., Yamada, H., Campbell, K. P., de La Torre, J. C. & Oldstone, M. B. A. (2000). Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med 192, 1249-1260.
116. Shimojima, M., Ströher, U., Ebihara, H., Feldmann, H. & Kawaoka, Y. (2012). Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. J Virol 86, 2067-2078.
117. Spiropoulou, C. F., Kunz, S., Rollin, P. E., Campbell, K. P. & Oldstone, M. B. A. (2002). New World arenavirus clade C, but not clade A and B viruses, utilizes α-dystroglycan as its major receptor. J Virol 76, 5140-5146.
118. Stinebaugh, B. J., Schloeder, F. X., Johnson, K. M., Mackenzie, R. B., Entwisle, G. & De Alba, E. (1966). Bolivian hemorrhagic fever. A report of four cases. Am J Med 40, 217-230.
119. Tesh, R. B., Jahrling, P. B., Salas, R. & Shope, R. E. (1994). Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am J Trop Med Hyg 50, 452-459.
120. Vela, E. (2012). Animal models, prophylaxis, and therapeutics for arenavirus infections. Viruses 4, 1802-1829.
121. Vela, E. M., Zhang, L., Colpitts, T. M., Davey, R. A. & Aronson, J. F. (2007). Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology 369, 1-11.
122. Vieth, S., Torda, A. E., Asper, M., Schmitz, H. & Günther, S. (2004). Sequence analysis of L RNA of Lassa virus. Virology 318, 153-168.
123. Walker, D. H., McCormick, J. B., Johnson, K. M., Webb, P. A., Komba-Kono, G., Elliott, L. H. & Gardner, J. J. (1982a). Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol 107, 349-356.
124. Walker, D. H., McCormick, J. B., Johnson, K. M., Webb, P. A., Komba-Kono, G., Elliott, L. H. & Gardner, J. J. (1982b). Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol 107, 349-356.
125. Webb, P. A., Justines, G. & Johnson, K. M. (1975). Infection of wild and laboratory animals with Machupo and Latino viruses. Bull World Health Organ 52, 493-499.
126. Weissenbacher, M. C., Laguens, R. P. & Coto, C. E. (1987). Argentine hemorrhagic fever. Curr Top Microbiol Immunol 134, 79-116.
127. Yamamoto, T., Kato, Y., Karita, M., Kawaguchi, M., Shibata, N. & Kobayashi, M. (2004). Expression of genes related to muscular dystrophy with lissencephaly. Pediatr Neurol 31, 183-190.
128. York, J. & Nunberg, J. H. (2007). Distinct requirements for signal peptidase processing and function in the stable signal peptide subunit of the Junín virus envelope glycoprotein. Virology 359, 72-81.
129. York, J., Romanowski, V., Lu, M. & Nunberg, J. H. (2004). The signal peptide of the Junín arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J Virol 78, 10783-10792.
130. Zapata, J. C. & Salvato, M. S. (2013). Arenavirus variations due to host-specific adaptation. Viruses 5, 241-278.